(S (NP (DT This) (NN work)) (VP (VBZ introduces) (NP (DT a) (NN method) (S (VP (TO to) (VP (VB tune) (NP (NP (DT a) (ADJP (NN sequence) (HYPH -) (VBN based)) (JJ generative) (NN model)) (PP (IN for) (NP (NP (JJ molecular) (ADJP (FW de) (FW novo)) (NN design)) (SBAR (WHNP (WHNP (WDT that)) (PP (IN through) (NP (VBN augmented) (JJ episodic) (NN likelihood)))) (S (VP (MD can) (VP (VB learn) (S (VP (TO to) (VP (VB generate) (NP (NNS structures)) (PP (IN with) (NP (JJ certain) (VBN specified) (JJ desirable) (NNS properties)))))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (WHADVP (WRB how)) (S (NP (DT this) (NN model)) (VP (MD can) (VP (VB execute) (NP (NP (DT a) (NN range)) (PP (IN of) (NP (NP (NNS tasks)) (PP (JJ such) (IN as) (S (VP (VP (VBG generating) (NP (NNS analogues)) (PP (IN to) (NP (DT a) (NN query) (NN structure)))) (CC and) (VP (VBG generating) (NP (NP (NNS compounds)) (VP (VBN predicted) (S (VP (TO to) (VP (VB be) (ADJP (JJ active) (PP (IN against) (NP (DT a) (JJ biological) (NN target))))))))))))))))))))) (. .))
(S (PP (IN As) (NP (NP (DT a) (NN proof)) (PP (IN of) (NP (NN principle))))) (, ,) (NP (DT the) (NN model)) (VP (VBZ is) (ADVP (JJ first)) (VP (VBN trained) (S (VP (TO to) (VP (VB generate) (NP (NP (NNS molecules)) (SBAR (WHNP (WDT that)) (S (VP (VBP do) (RB not) (VP (VB contain) (NP (NN sulphur)))))))))))) (. .))
(S (PP (IN As) (NP (DT a) (JJ second) (NN example))) (, ,) (NP (DT the) (NN model)) (VP (VBZ is) (VP (VBN trained) (S (VP (TO to) (VP (VB generate) (NP (NNS analogues)) (PP (IN to) (NP (NP (DT the) (NN drug) (NNP Celecoxib)) (, ,) (NP (NP (DT a) (NN technique)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB be) (VP (VBN used) (PP (IN for) (NP (NP (NN scaffold)) (VP (VBG hopping)))))))))) (CC or) (NP (NP (NN library) (NN expansion)) (VP (VBG starting) (PP (IN from) (NP (DT a) (JJ single) (NN molecule)))))))))))) (. .))
(S (ADVP (RB Finally)) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBG tuning) (NP (DT the) (NN model)) (PP (IN towards) (NP (NP (VBG generating) (NNS compounds)) (VP (VBN predicted) (S (VP (TO to) (VP (VB be) (ADJP (JJ active) (PP (IN against) (NP (NP (DT the) (NML (NN dopamine) (NN receptor)) (NN type)) (NP-TMP (CD 2)))))))))))))) (, ,) (NP (DT the) (NN model)) (VP (VBZ generates) (NP (NP (NNS structures)) (PP (IN of) (SBAR (WHNP (WDT which)) (S (NP (QP (JJR more) (IN than) (CD 95)) (NN %)) (VP (VBP are) (VP (VBN predicted) (S (VP (TO to) (VP (VB be) (ADJP (JJ active))))) (, ,) (PP (VBG including) (NP (NP (ADJP (RB experimentally) (VBN confirmed)) (NNS actives)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN included) (PP (IN in) (NP (CC either) (NP (DT the) (JJ generative) (NN model)) (CC nor) (NP (DT the) (NN activity) (NN prediction) (NN model)))))))))))))))))) (. .))
